ADVM
Price
$2.88
Change
-$0.14 (-4.64%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
64.42M
CNTX
Price
$0.87
Change
+$0.02 (+2.35%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
76.05M
49 days until earnings call
Interact to see
Advertisement

ADVM vs CNTX

Header iconADVM vs CNTX Comparison
Open Charts ADVM vs CNTXBanner chart's image
Adverum Biotechnologies
Price$2.88
Change-$0.14 (-4.64%)
Volume$100
Capitalization64.42M
Context Therapeutics
Price$0.87
Change+$0.02 (+2.35%)
Volume$100
Capitalization76.05M
ADVM vs CNTX Comparison Chart in %
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. CNTX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Hold and CNTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (ADVM: $3.02 vs. CNTX: $0.85)
Brand notoriety: ADVM and CNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 30% vs. CNTX: 48%
Market capitalization -- ADVM: $64.42M vs. CNTX: $76.05M
ADVM [@Biotechnology] is valued at $64.42M. CNTX’s [@Biotechnology] market capitalization is $76.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileCNTX’s FA Score has 1 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • CNTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADVM and CNTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 5 TA indicator(s) are bullish while CNTX’s TA Score has 3 bullish TA indicator(s).

  • ADVM’s TA Score: 5 bullish, 5 bearish.
  • CNTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ADVM is a better buy in the short-term than CNTX.

Price Growth

ADVM (@Biotechnology) experienced а -12.97% price change this week, while CNTX (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was +6.99%, and the average quarterly price growth was +35.85%.

Reported Earning Dates

CNTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTX($76.1M) has a higher market cap than ADVM($64.4M). CNTX YTD gains are higher at: -19.257 vs. ADVM (-35.332). CNTX has higher annual earnings (EBITDA): -38.29M vs. ADVM (-172.21M). CNTX has more cash in the bank: 83.5M vs. ADVM (44.4M). CNTX has less debt than ADVM: CNTX (167K) vs ADVM (92.2M). ADVM has higher revenues than CNTX: ADVM (1M) vs CNTX (0).
ADVMCNTXADVM / CNTX
Capitalization64.4M76.1M85%
EBITDA-172.21M-38.29M450%
Gain YTD-35.332-19.257183%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash44.4M83.5M53%
Total Debt92.2M167K55,210%
FUNDAMENTALS RATINGS
ADVM: Fundamental Ratings
ADVM
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVMCNTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRAFF0.220.02
+8.35%
Sandfire Resources America Inc.
BLRDF9.08N/A
N/A
Billerud AB
BSHI14.00N/A
N/A
Boss Holdings, Inc.
HAIUF11.10N/A
N/A
Healthcare AI Acquisition Corp.
ORKLY11.19-0.26
-2.31%
Orkla ASA

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with XENE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-1.63%
XENE - ADVM
49%
Loosely correlated
-0.92%
RGNX - ADVM
48%
Loosely correlated
+1.87%
OCUL - ADVM
47%
Loosely correlated
-0.84%
NRIX - ADVM
46%
Loosely correlated
-2.65%
VYGR - ADVM
46%
Loosely correlated
+0.95%
More

CNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with IPSC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+4.43%
IPSC - CNTX
34%
Loosely correlated
-1.49%
RXRX - CNTX
30%
Poorly correlated
+1.47%
CMMB - CNTX
29%
Poorly correlated
-0.71%
PROK - CNTX
29%
Poorly correlated
+6.94%
ADVM - CNTX
29%
Poorly correlated
-1.63%
More